News

UK introduces new meningitis C vaccine

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7205.278 (Published 31 July 1999) Cite this as: BMJ 1999;319:278
  1. Jacqui Wise
  1. London

    A vaccination programme against meningococcal group C infection is to start this October in the United Kingdom in a bid to halve the total number of deaths from meningitis. The United Kingdom will be the first country in the world to implement such a vaccination programme following the development of a new meningitis C vaccine.

    The new vaccine, unlike the existing one, provides long term protection and can be used in babies and young children. The meningococcal surface polysaccharide is conjugated with a protein using similar technology to that used for the first time with the haemophilus influenzae type b (Hib) vaccine.

    Three manufacturers have developed the vaccine. One has submitted a licence application with the Medicines Control Agency and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe